Skip to main content
SpringerLink
Log in

Molecular Docking Analysis of Siddha Formulation Parangipattai Chooranam Against Vaginal Candidiasis

  • Original Article
  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Vulvovaginal candidiasis called by its name Vellai Noi as per Siddha terminology is considerably the second most common cause of vaginal inflammation in the women of middle-aged group. Candida albicans are prioritised top among other pathogens in mediating vaginal inflammation and its related symptoms. Candida albicans exerts its virulence by secreting the enzyme known as secreted aspartyl proteinases (SAP) which allows hassle-free adherence and growth of the opportunistic pathogen. Hence, drugs that selectively inhibit this enzyme may act as a novel candidate drug in halting the growth and invasion of Candida albicans. Siddha formulations have century’s old credit of managing infectious pathogens. The greater ideology of siddha practice is to adequately strengthen the host immunity and resistance towards infections. In the present investigation, about twelve phytocompounds have been retrieved from the siddha formulation Parangipattai Chooranam and the same were subjected to molecular docking analysis against SAP enzyme target along with standard fluconazole. Results of the present in silico investigation signify that the compounds such as beta-sitosterol, afzelin, apigenin, quercetin and rosmarinic acid ranked first by demonstrating potential binding affinity with active amino acid residues by occupying the respective binding sites (Asp 32, 83 Lys, Asp86, Gly220, Thr221 and Thr222) in comparison with standard drug fluconazole. Similar binding behaviour was exhibited by other compounds like kaempferol, carnosic acid and engeletin (Asp 32, Gly85, Asp86, Asp218, Gly220, Thr221 and Thr222) against the target amino acids. Vicenin exhibited best binding affinity of − 12.07 kcal/mol followed by beta-sitosterol (− 9.29 kcal/mol), engeletin (− 9.04 kcal/mol), afzelin (− 8.07 kcal/mol) and 4-O-caffeoylquinic acid (− 7.85 kcal/mol) in comparison with fluconazole (− 7.32 kcal/mol). From the results of the present study, it was concluded that the phytochemicals present in the siddha formulation Parangipattai Chooranam reveal significant antifungal activity by inhibiting the target enzyme (SAP) and thereby considered an excellent drug of choice for the clinical management of vaginal candidiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Martin Lopez, J. E. (2015). Candidiasis (vulvovaginal). BMJ Clinical Evidence, 2015:0815.

  2. Yano, J., Sobel, J. D., Nyirgesy, P., Sobel, R., Valerie, L. W., Yu, Q., Noverr, M. C., & Fidel, P. L. (2019). Current patient perspectives of vulvovaginal candidiasis: Incidence, symptoms, management and post-treatment outcomes. BMC Women’s Health, 19(1), 48. https://doi.org/10.1186/s12905-019-0748-8

    Article  PubMed  PubMed Central  Google Scholar 

  3. Nobile, C. J., & Johnson, A. D. (2015). Candida albicans biofilms and human disease. Annual Review of Microbiology, 69, 71–92. https://doi.org/10.1146/annurev-micro-091014-104330

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Spampinato, C., & Leonardi, D. (2013). Candida infections, causes, targets, and resistance mechanisms: Traditional and alternative antifungal agents. BioMed Research International, 204–237.https://doi.org/10.1155/2013/204237

  5. Staniszewska, M., Bondaryk, M., Piłat, J., Siennicka, K., Magda, U., & Kurzatkowski, W. (2012). Virulence factors of Candida albicans. Przeglad Epidemiologiczny, 66(4), 629–633.

    PubMed  Google Scholar 

  6. Monod, M., Togni, G., Hube, B., & Sanglard, D. (1994). Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Molecular Microbiology, 13, 357–368.

    Article  CAS  Google Scholar 

  7. Meng, X. Y., Zhang, H. X., Mezei, M., & Cui, M. (2011). Molecular docking: A powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146–157. https://doi.org/10.2174/157340911795677602

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Krishna Veni, R., & Meenambiga, S. S. (2019). In-silico analysis of endophytic fungal metabolites against secreted aspartic proteinase enzyme of Candida albicans. Research Journal of Pharmacy and Technology, 12(7), 3495–3500.

    Article  Google Scholar 

  9. Thas, J. J. (2008). Siddha medicine-background and principles and the application for skin diseases. Clinics in Dermatology, 26(1), 62–78.

    Article  Google Scholar 

  10. KuppusamyMudaliar, K. N., & Uthamarayan, K. S. (1998). Siddha Vaithiya Thirattu (1st ed., pp. 221–222). Chennai: Canaan Press.

    Google Scholar 

  11. Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Stefano, F., Ruth, H., Michael, E. P., Michel, F. S., & David, S. G. (2016). Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols, 11, 905–919.

    Article  Google Scholar 

  13. Osterberg, F., Morris, G. M., Sanner, M. F., Olson, A. J., & Goodsell, D. S. (2002). Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins, 46, 34–40.

    Article  CAS  Google Scholar 

  14. Morris, G. M. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19, 1639–1662.

    Article  CAS  Google Scholar 

  15. Abirami, G., Alexpandi, R., Durgadevi, R., Kannappan, A., & Veeraravi, A. (2020). Inhibitory effect of morin against Candida albicans pathogenicity and virulence factor production: An in vitro and in vivo approaches. Frontiers in Microbiology, 11, 1–16. https://doi.org/10.3389/fmicb.2020.561298

    Article  Google Scholar 

  16. d’Enfert, C., Kaune, A. K., Alaban, L. R., et al. (2021). The impact of the fungus-host-microbiota interplay upon Candida albicans infections: Current knowledge and new perspectives. FEMS Microbiology Reviews, 45(3), fuaa060. https://doi.org/10.1093/femsre/fuaa060

    Article  CAS  PubMed  Google Scholar 

  17. Chen, H., Zhou, X., Ren, B., & Cheng, L. (2020). The regulation of hyphae growth in Candida albicans. Virulence, 11(1), 337–348. https://doi.org/10.1080/21505594.2020.1748930

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Houst, J., Spizek, J., & Havlicek, V. (2020). Antifungal drugs. Metabolites., 10(3), 106. https://doi.org/10.3390/metabo10030106

    Article  CAS  PubMed Central  Google Scholar 

  19. Ekor, M. (2014). The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, 177. https://doi.org/10.3389/fphar.2013.00177

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Jadhav, P., Kapoor, N., Thomas, B., Lal, H., & Kshirsagar, N. (2012). Antiviral potential of selected Indian medicinal (ayurvedic) plants against herpes simplex virus 1 and 2. North American Journal of Medical Sciences, 4(12), 641–647. https://doi.org/10.4103/1947-2714.104316

    Article  PubMed  PubMed Central  Google Scholar 

  21. Pinzi, L., & Rastelli, G. (2019). Molecular docking: Shifting paradigms in drug discovery. International Journal of Molecular Sciences, 20(18), 4331. https://doi.org/10.3390/ijms20184331

    Article  CAS  PubMed Central  Google Scholar 

  22. Sivaraman, D., Pradeep, P. S., Sundar Manoharan, S., Ramachandra Bhat, C., Leela, K. V., & Venugopal, V. (2020). Revealing potential binding affinity of FDA approved therapeutics targeting main protease (3CLpro) in impairing novel coronavirus (SARS-CoV-2) replication that causes COVID-19. Coronaviruses, 1, 98–107. https://doi.org/10.2174/2666796701999200701122817

    Article  CAS  Google Scholar 

  23. Sivaraman, D., & Pradeep, P. S. (2020). Exploration of bioflavonoids targeting dengue virus NS5 RNA dependent RNA polymerase: In silico molecular docking approach. Journal of Applied Pharmaceutical Science, 10(5), 16–22. https://doi.org/10.7324/JAPS.2020.10503

    Article  CAS  Google Scholar 

  24. Patra, A. K. (2012). An overview of antimicrobial properties of different classes of phytochemicals. Dietary Phytochemicals and Microbes, 1–32.https://doi.org/10.1007/978-94-007-3926-0_1.

Download references

Acknowledgements

We wish to acknowledge Sri Sairam Siddha Medical College & Research Centre, Chennai, Tamil Nadu, India, and The Noble research solutions, Chennai, Tamil Nadu, India, for their support.

Author information

Authors and Affiliations

  1. Department of Nunnuyiriyal, Sri Sairam Siddha Medical College and Research Centre, Chennai, Tamil Nadu, India

    V. Poorna Pushkala

  2. Department of Sool Magalir Maruthuvam, Sri Sairam Siddha Medical College and Research Centre, Chennai, Tamil Nadu, India

    S. Mary Princess Sulekha

  3. Department of Kuzhanthai Maruthuvam, Sri Sairam Siddha Medical College and Research Centre, Chennai, Tamil Nadu, India

    S. Mathukumar

  4. Sri Sairam Siddha Medical College and Research Centre, CRRI, Chennai, Tamil Nadu, India

    B. Ragavi & U. Sowmiya

Authors
  1. V. Poorna Pushkala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Mary Princess Sulekha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Mathukumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Ragavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. Sowmiya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Poorna Pushkala.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pushkala, V.P., Sulekha, S.M.P., Mathukumar, S. et al. Molecular Docking Analysis of Siddha Formulation Parangipattai Chooranam Against Vaginal Candidiasis. Appl Biochem Biotechnol 194, 1039–1050 (2022). https://doi.org/10.1007/s12010-022-03813-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-022-03813-y

Keywords

Search

Navigation